(Q38196920)

30 August 2017

1 reference

title

Circulating tumor cells as promising novel biomarkers in solid cancers (English)

1 reference

30 August 2017

0 references

Evi S Lianidou

1

1 reference

30 August 2017

Areti Strati

series ordinal

2

1 reference

30 August 2017

Athina Markou

series ordinal

3

1 reference

30 August 2017

publication date

19 March 2014

1 reference

Critical Reviews in Clinical Laboratory Sciences

30 August 2017

published in

1 reference

30 August 2017

volume

51

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

160-171

1 reference

Cancer. Circulating tumor cells

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells: approaches to isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells: liquid biopsy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

CTCs in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumour cells in non-metastatic breast cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Biomarkers characterization of circulating tumour cells in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Epithelial-mesenchymal transitions: insights from development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Plasticity of disseminating cancer cells in patients with epithelial malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Apoptotic circulating tumor cells in early and metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells as biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Validation and clinical utility of prostate cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Unique localization of circulating tumor cells in patients with hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

The clinical significance of circulating tumor cells in non-metastatic colorectal cancer--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells in high-risk nonmetastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.896316

10.3109/10408363.2014.896316

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference